• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘氨醇及其甲基化衍生物N,N-二甲基鞘氨醇(DMS)可在多种人类癌细胞系中诱导细胞凋亡。

Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines.

作者信息

Sweeney E A, Sakakura C, Shirahama T, Masamune A, Ohta H, Hakomori S, Igarashi Y

机构信息

The Biomembrane Institute, University of Washington, Seattle, 98119, USA.

出版信息

Int J Cancer. 1996 May 3;66(3):358-66. doi: 10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO;2-7.

DOI:10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO;2-7
PMID:8621258
Abstract

In the study of apoptosis initiated by various signals including ligands binding to cell membrane receptors such as Fas and TNFRI, the sphingomyelin pathway and its resulting metabolites, the sphingolipids, have been suggested to be involved in the signaling pathway. In earlier studies we presented data which indicated that sphingosine (Sph) itself was increased during apoptosis induced by phorbol myristate acetate (PMA) in HL60 cells and tumor necrosis factor (TNF) in neutrophils, and when added exogenously was able to induce apoptosis. We report here that Sph and its methylated derivative N,N,-dimethylsphingosine (DMS) are able to induce apoptosis in cancer cells of both hematopoietic and carcinoma origin. In human leukemic cell lines CMK-7, HL60 and U937, treatment with 20 microM Sph for 6 hr caused apoptosis in up to 90% of cells. Human colonic carcinoma cells HT29, HRT18, MKN74 and COLO205 were shown to be more susceptible to apoptosis upon addition of DMS (>50%) than of Sph (<50%), yet were weakly or not sensitive to N,N,N-trimethylsphingosine (TMS). Under the same conditions, in the presence of serum, neither Sph-1-phosphate nor ceramide analogues C2-, C6- or C8-ceramide were able to induce apoptosis in any cell lines. However, in the absence of serum, ceramide analogues induced apoptosis in leukemia cell lines after 18 hr, yet much less so than Sph or DMS. Furthermore, apoptosis induced by Sph or DMS could not be inhibited by the ceramide synthase inhibitor fumonisin B1. Apoptosis was not induced by sphingolipids in primary culture cells, such as HUVEC or rat mesangial cells, but was apparent in transformed rat mesangial cells. Additionally, apoptosis induced by Sph, DMS or C2Cer was inhibited by protease inhibitors. Our data further support the evidence that the catabolic pathway of sphingomyelin involving Sph and other metabolites is an integral part of the apoptosis pathway.

摘要

在对包括与Fas和TNFRI等细胞膜受体结合的配体在内的各种信号引发的细胞凋亡研究中,鞘磷脂途径及其产生的代谢产物鞘脂类物质被认为参与了信号通路。在早期研究中,我们提供的数据表明,在佛波酯(PMA)诱导HL60细胞凋亡以及肿瘤坏死因子(TNF)诱导中性粒细胞凋亡的过程中,鞘氨醇(Sph)自身含量增加,并且外源性添加时能够诱导细胞凋亡。我们在此报告,Sph及其甲基化衍生物N,N,-二甲基鞘氨醇(DMS)能够诱导造血来源和癌来源的癌细胞发生凋亡。在人白血病细胞系CMK-7、HL60和U937中,用20微摩尔/升的Sph处理6小时,高达90%的细胞发生凋亡。人结肠癌细胞HT29、HRT18、MKN74和COLO205在添加DMS(>50%)时比添加Sph(<50%)时对凋亡更敏感,但对N,N,N-三甲基鞘氨醇(TMS)反应较弱或不敏感。在相同条件下,有血清存在时,鞘氨醇-1-磷酸以及神经酰胺类似物C2-、C6-或C8-神经酰胺均不能在任何细胞系中诱导凋亡。然而,无血清时,神经酰胺类似物在18小时后可诱导白血病细胞系发生凋亡,但程度远低于Sph或DMS。此外, 鞘氨醇合酶抑制剂伏马菌素B1不能抑制Sph或DMS诱导的凋亡。鞘脂类物质在原代培养细胞如人脐静脉内皮细胞(HUVEC)或大鼠系膜细胞中不诱导凋亡,但在转化的大鼠系膜细胞中则明显诱导凋亡。另外,Sph、DMS或C2神经酰胺诱导的凋亡可被蛋白酶抑制剂抑制。我们的数据进一步支持了以下证据,即涉及Sph和其他代谢产物的鞘磷脂分解代谢途径是细胞凋亡途径的一个组成部分。

相似文献

1
Sphingosine and its methylated derivative N,N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines.鞘氨醇及其甲基化衍生物N,N-二甲基鞘氨醇(DMS)可在多种人类癌细胞系中诱导细胞凋亡。
Int J Cancer. 1996 May 3;66(3):358-66. doi: 10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO;2-7.
2
In vitro and in vivo induction of apoptosis by sphingosine and N, N-dimethylsphingosine in human epidermoid carcinoma KB-3-1 and its multidrug-resistant cells.鞘氨醇和N,N - 二甲基鞘氨醇在人表皮样癌KB - 3 - 1及其多药耐药细胞中诱导细胞凋亡的体外和体内研究
Clin Cancer Res. 1997 Feb;3(2):257-64.
3
Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation.鞘氨醇诱导人白血病HL-60细胞凋亡:一种可能参与佛波酯诱导分化过程中凋亡性DNA片段化的内源性调节因子
Cancer Res. 1995 Feb 1;55(3):691-7.
4
Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide.半胱天冬酶抑制剂对鞘脂诱导的细胞凋亡的抑制作用表明,鞘氨醇在细胞凋亡途径中比神经酰胺作用于更早的阶段。
FEBS Lett. 1998 Mar 20;425(1):61-5. doi: 10.1016/s0014-5793(98)00198-7.
5
Inhibition of MAP kinase by sphingosine and its methylated derivative, N,N-dimethylsphingosine.鞘氨醇及其甲基化衍生物N,N - 二甲基鞘氨醇对丝裂原活化蛋白激酶的抑制作用
Int J Oncol. 1997 Jul;11(1):31-9. doi: 10.3892/ijo.11.1.31.
6
N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.N,N-二甲基鞘氨醇对人血小板中鞘氨醇激酶和1-磷酸鞘氨醇活性的抑制作用
Biochemistry. 1996 Jan 16;35(2):626-33. doi: 10.1021/bi9515533.
7
1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase.1α,25-二羟基维生素D3通过激活鞘氨醇激酶抑制HL-60细胞中的程序性细胞死亡。
Cancer Res. 1998 May 1;58(9):1817-24.
8
Induction of apoptosis and potentiation of TNF- and Fas-mediated apoptosis in U937 cells by the xanthogenate compound D609.黄原酸酯化合物D609诱导U937细胞凋亡以及增强TNF和Fas介导的细胞凋亡
Exp Cell Res. 1997 Aug 25;235(1):48-54. doi: 10.1006/excr.1997.3641.
9
Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons.细胞内的1-磷酸鞘氨醇介导了神经生长因子在大鼠感觉神经元中产生的兴奋性增加。
J Physiol. 2006 Aug 15;575(Pt 1):101-13. doi: 10.1113/jphysiol.2006.111575. Epub 2006 Jun 1.
10
[Effect of sphingosine kinase 1 on the apoptosis, migration and invasion of colon cancer HT-29 cells and its molecular mechanisms].[鞘氨醇激酶1对结肠癌HT-29细胞凋亡、迁移及侵袭的影响及其分子机制]
Zhonghua Zhong Liu Za Zhi. 2011 Mar;33(3):178-82.

引用本文的文献

1
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.癌症中的鞘氨醇-1-磷酸代谢途径:对治疗靶点的影响
Int J Mol Sci. 2025 Jan 26;26(3):1056. doi: 10.3390/ijms26031056.
2
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer.靶向鞘氨醇-1-磷酸代谢作为前列腺癌的一种治疗途径
Cancers (Basel). 2023 May 12;15(10):2732. doi: 10.3390/cancers15102732.
3
A Comprehensive Metabolomics Analysis of Fecal Samples from Advanced Adenoma and Colorectal Cancer Patients.
晚期腺瘤和结直肠癌患者粪便样本的综合代谢组学分析
Metabolites. 2022 Jun 15;12(6):550. doi: 10.3390/metabo12060550.
4
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases.基于鞘氨醇激酶1(SphK1)在炎症免疫相关疾病中的异常表达探讨SphK1抑制剂的治疗潜力
Front Pharmacol. 2021 Oct 19;12:733387. doi: 10.3389/fphar.2021.733387. eCollection 2021.
5
Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy.在癌症治疗药物研发中靶向鞘氨醇激酶/1-磷酸鞘氨醇信号轴
Cancers (Basel). 2021 Apr 15;13(8):1898. doi: 10.3390/cancers13081898.
6
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
7
Sphingolipids as Emerging Mediators in Retina Degeneration.鞘脂作为视网膜变性中新兴的介质。
Front Cell Neurosci. 2019 Jun 11;13:246. doi: 10.3389/fncel.2019.00246. eCollection 2019.
8
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.新型基于神经酰胺的癌症治疗药物在个性化医疗时代的应用
Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19.
9
Targeting Sphingosine Kinases for the Treatment of Cancer.靶向鞘氨醇激酶治疗癌症。
Adv Cancer Res. 2018;140:295-325. doi: 10.1016/bs.acr.2018.04.015. Epub 2018 Jun 9.
10
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice.鞘氨醇激酶1的缺失抑制二乙基亚硝胺处理小鼠的肝脏肿瘤发生。
Oncotarget. 2018 Feb 26;9(21):15635-15649. doi: 10.18632/oncotarget.24583. eCollection 2018 Mar 20.